Colorectal cancer and dostarlimab - An episode in discovery to new era of immunotherapy
J Cancer Res Ther
.
2023 Jul-Sep;19(5):1490-1491.
doi: 10.4103/jcrt.jcrt_1184_22.
Authors
Lakshmi Deepak Bethineedi
1
,
L V Simhachalam Kutikuppala
2
,
Sri Harsha Boppana
3
,
Sai Kiran Kuchana
4
,
Sai Venkata Kalyani Ponnaganti
5
Affiliations
1
Department of General Surgery, Andhra Medical College, Visakhapatnam, Andhra Pradesh, India.
2
Department of General Surgery, Dr. NTR University of Health Sciences, Vijayawada, Andhra Pradesh, India.
3
Department of Anaesthesiology, Division of Perioperative Informatics, University of California, San Diego, La Jolla, CA, USA.
4
Department of General Surgery, Kakatiya Medical College, Warangal, Telangana, India.
5
Department of General Surgery, Rangaraya Medical College, Kakinada, Andhra Pradesh, India.
PMID:
37787342
DOI:
10.4103/jcrt.jcrt_1184_22
No abstract available
Publication types
Letter
MeSH terms
Colorectal Neoplasms* / drug therapy
Humans
Immunotherapy*
Substances
dostarlimab